Tag: spinal muscular atrophy

The era of Gene therapy, and the Billion Dollar tag

Articles

The era, we are living in has experienced many advancements in the healthcare system. Curative, and life-changing gene therapies have...

Read More

Meet the World’s most expensive drug: Zolgensma

Articles

The U.S. FDA recently approved the much talked about Novartis’s drug Zolgensma for treating a life-threatening condition Spinal Muscular...

Read More

Spinal Muscular Atrophy Market is expected to augment at a CAGR of 10.42%

Articles, Business Consultant, DelveInsight's Drug Report, DelveInsight's Indication Pipeline Reports, Pharma Consultant

Spinal Muscular Atrophy (SMA) is a genetic disorder that affects the part of the nervous system which controls the voluntary movement of...

Read More

Can Spinal Muscular Atrophy be treated by Protease Inhibitors?

Business Consultant, DelveInsight's Drug Report, DelveInsight's Indication Pipeline Reports, new therapeutic target, Pharma Consultant, Snippets • 2 Comments

Spinal muscular atrophy is a genetic disorder characterised by weakness and wasting (atrophy) of skeletal muscles, used for movement. Loss...

Read More
Close